Work

A Phase 2 Study Evaluating Axitinib in Patients With Unresectable, Recurrent, or Metastatic Head and Neck Cancer

Year: 2016

Type: article

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2015.12.269

Authors: P. Swiecicki, E. Dickerson, A. Srinivasan, L. Zhao, E. Bellile, A.G. Sacco, D.B. Chepeha, I. Dobrosotskaya, M.E. Spector, A. Shuman, K. Malloy, J. Moyer, E. McKean, G.T. Wolf, A. Eisbruch, M. Prince, C. Bradford, T. Carey, F.P. Worden

Institutions: U-M Rogel Cancer Center, Moores Cancer Center, Henry Ford Hospital, University of Michigan

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2289398136

FWCI: 0.291

Cites:

Cited by: 1

Related to: 10